Abstract
Precisely diagnosing metabolic dysfunction-associated fatty liver disease (MAFLD) and its severity degree can effectively delay disease progression and have important guiding values for treatment. In recent years, research on non-invasive diagnosis of metabolic dysfunction-associated fatty liver disease has made great progress, suggesting that we should not only give full play advantage to professional personnel in the field of liver disease but also actively cooperate with personnel in other fields to explore different high-performance non-invasive diagnostic methods to achieve early detection, diagnosis, and treatment.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Paper Title
Journal
Date
